Press release
Joint Pain Injections Market Forecast 2024: Global Insights and Trends
Joint Pain Injections Market Forecast
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp
According to The Business Research Company's, The joint pain injections market size has grown rapidly in recent years. It will grow from $5.19 billion in 2023 to $5.75 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increased aging population, arthritis prevalence, global health initiatives, healthcare digitalization, increasing awareness of chronic pain management.
The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $8.8 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expansion of telehealth services, personalized pain management, patient education and empowerment, sustainable healthcare practices, nutritional support. Major trends in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, artificial intelligence ai-enhanced injections.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report
Market Drivers and Trends:
The rise in the prevalence of arthritis and musculoskeletal disorders will propel the growth of the joint pain injections market. Musculoskeletal disorders are the biggest cause of disability worldwide, with low back pain being the single most common cause of impairment in 160 nations. Patients are taking injections for pain relief and inflammatory condition. For instance, in February 2021, according to the report published by WHO, approximately 1.71 billion people in the world are affected by musculoskeletal conditions and the number of people with musculoskeletal disorders is continuously growing due to population growth and aging. Similarly, in 2021, according to the report by Global RA Network, arthritis affects about 350 million people worldwide and increasing rapidly. Therefore, the rising prevalence of arthritis and musculoskeletal disorder drives the joint pain injections market.
New product development is a key trend gaining popularity in the joint pain injections market. Major companies operating in the join pain injections sector are focused on new product innovations to meet consumer demand and strengthen their position. In September 2021, Contura International Ltd., a UK-based manufacturer of innovative therapeutic hydrogels, launched Arthrosamid. Arthrosamid is an innovative hydrogel injection for knee osteoarthritis that uses non-biodegradable hydrogel technology, offers an alternative to existing treatments, satisfies a clinical need for a potent, long-lasting, secure, and minimally intrusive method of treating knee osteoarthritis pain (OA).
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited
Joint Pain Injections Market 2024 Key Insights:
• The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $8.8 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%.
• Elevated Prevalence Of Arthritis And Musculoskeletal Disorders Drives Growth In The Joint Pain Injections Market
• Contura International Ltd. Revolutionizes Knee Osteoarthritis Treatment With Arthrosamid
• North America was the largest region in the joint pain injections market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=6482&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Joint Pain Injections Market Forecast 2024: Global Insights and Trends here
News-ID: 3732093 • Views: …
More Releases from The Business Research Company
Surgical Meshes Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Surgical Meshes Market Size By 2025?
In the past few years, the market size of surgical meshes has seen significant growth. It is projected to expand from $2.03 billion in 2024 to $2.18 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 7.3%.…
Rehabilitation Equipment Market Poised to Hit $23.97 Billion by 2029 with Accele …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Rehabilitation Equipment Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a significant growth in the size of the rehabilitation equipment market. Projected to increase from $17.36 billion in 2024, it is expected to reach $18.49 billion in 2025, with a compound annual…
Future of the Pediatric Neurology Device Market: Strategic Analysis and Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pediatric Neurology Device Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pediatric neurology devices has seen significant expansion in recent years, climbing from $2.5 billion in 2024 to an anticipated $2.65 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Orthokeratology Lens Market Through 2025?
The market for orthokeratology lenses has seen a significant increase in size over recent years. It's projected to expand from $2.56 billion in 2024 to $2.75 billion in 2025, with a compound annual growth rate (CAGR) of…
More Releases for Joint
"Joint Genesis Launches Revolutionary Natural Supplement for Joint Pain Relief & …
Joint Genesis has officially launched its breakthrough natural supplement designed to provide effective joint pain relief, improve mobility, and support long-term joint regeneration. This scientifically inspired formula combines powerful natural ingredients to help adults maintain an active lifestyle, reduce stiffness, and support overall joint health. Joint GenesisTM is ideal for anyone looking for a safe, natural alternative to traditional painkillers. Customers can purchase the supplement online at https://us-jointgenesisis.com
and experience…
Arthro MD+ Joint Support - Enhance Mobility And Joint Stability!
As we age or engage in physically demanding activities, our joints often take the brunt of the damage. Stiffness, pain, and reduced flexibility can limit mobility and affect our quality of life. This is where Arthro MD+ Joint Support comes into play. In this comprehensive guide, we will explore everything you need to know about this joint supplement, from its benefits to how it works, customer reviews, and more. By…
Pharma Flex RX Joint Support™ Healthy Joint Mobility Flexibility!
Are you tired of living with joint pain, inflammation, and arthritis? Pharma Flex RX Joint Support is here to help. This is made to ease your joint pain and support your health. It uses natural ingredients that work together to fix the real causes of your joint pain. This means you can move freely and enjoy your life again.
● Product Name - Pharma Flex RX Joint Support
● Results - In…
BioDynamix Joint Genesis - Time To Say Bye To Joint Pain (Joint Genesis Reviews)
What is BioDynamix Joint Genesis?
BioDynamix Joint Genesis is a doctor-formulated supplement designed to treat joint pain and discomfort. The formula rejuvenates and restores your joints, offering a pain-free life.
BioDynamix Joint Genesis ensures you enjoy flexibility, movement, and independence for a long time. It soothes all kinds of joint inflammation and combats stiffness. The formula works by addressing the underlying cause of joint issues.
BioDynamix Joint Genesis works for adults between ages…
Revolutionizing Sacroiliac Joint Treatment: Minimally Invasive Sacroiliac Joint …
Minimally Invasive Sacroiliac Joint Fusion (MIS-SIJ Fusion) is a surgical procedure for treating sacroiliac joint disorders, where the sacroiliac joint is stabilized through minimally invasive techniques. MIS sacroiliac joint fusion is a less invasive alternative to traditional open sacroiliac joint fusion and is gaining popularity among patients and healthcare providers. The MIS sacroiliac joint fusion market is expected to grow significantly in the coming years, driven by the increasing demand…
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big…
